H.W. Tilanus

7.5k total citations
54 papers, 1.6k citations indexed

About

H.W. Tilanus is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, H.W. Tilanus has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 29 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in H.W. Tilanus's work include Esophageal Cancer Research and Treatment (26 papers), Gastric Cancer Management and Outcomes (18 papers) and Esophageal and GI Pathology (18 papers). H.W. Tilanus is often cited by papers focused on Esophageal Cancer Research and Treatment (26 papers), Gastric Cancer Management and Outcomes (18 papers) and Esophageal and GI Pathology (18 papers). H.W. Tilanus collaborates with scholars based in Netherlands, United States and United Kingdom. H.W. Tilanus's co-authors include Peter D. Siersema, Ernst J. Kuipers, Laurents P. S. Stassen, Herold J. Metselaar, Ate van der Gaast, M. van Blankenstein, W. C. J. Hop, Pieter Honkoop, Marjolein Y.V. Homs and Peter D. Siersema and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

H.W. Tilanus

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.W. Tilanus Netherlands 22 1.0k 867 210 168 162 54 1.6k
Richard J. Finley Canada 29 1.0k 1.0× 1.2k 1.4× 101 0.5× 47 0.3× 160 1.0× 79 2.1k
Subhas Banerjee United States 27 2.1k 2.0× 1.2k 1.3× 193 0.9× 73 0.4× 639 3.9× 43 3.0k
U Denzer Germany 22 626 0.6× 388 0.4× 508 2.4× 555 3.3× 183 1.1× 72 1.4k
Madhav Desai United States 23 868 0.8× 887 1.0× 105 0.5× 71 0.4× 569 3.5× 98 1.7k
Ali Abbas United States 21 632 0.6× 203 0.2× 349 1.7× 96 0.6× 180 1.1× 52 1.2k
Joseph I. Miller United States 31 1.8k 1.7× 1.8k 2.0× 310 1.5× 26 0.2× 358 2.2× 105 3.3k
Kelly Hathorn United States 20 782 0.7× 451 0.5× 140 0.7× 48 0.3× 268 1.7× 73 1.3k
Laith H. Jamil United States 28 1.5k 1.4× 816 0.9× 697 3.3× 301 1.8× 828 5.1× 112 2.8k
Krishnavel V. Chathadi United States 21 1.5k 1.4× 947 1.1× 214 1.0× 136 0.8× 819 5.1× 28 2.2k
James T. Mayes United States 24 1.0k 1.0× 309 0.4× 228 1.1× 290 1.7× 120 0.7× 53 1.9k

Countries citing papers authored by H.W. Tilanus

Since Specialization
Citations

This map shows the geographic impact of H.W. Tilanus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.W. Tilanus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.W. Tilanus more than expected).

Fields of papers citing papers by H.W. Tilanus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.W. Tilanus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.W. Tilanus. The network helps show where H.W. Tilanus may publish in the future.

Co-authorship network of co-authors of H.W. Tilanus

This figure shows the co-authorship network connecting the top 25 collaborators of H.W. Tilanus. A scholar is included among the top collaborators of H.W. Tilanus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.W. Tilanus. H.W. Tilanus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Leeuwenburgh, Ivonne, Pieter Scholten, Joyce Alderliesten, et al.. (2010). Long-Term Esophageal Cancer Risk in Patients With Primary Achalasia: A Prospective Study. The American Journal of Gastroenterology. 105(10). 2144–2149. 114 indexed citations
3.
Hoven, Ben van der, Hans van Pelt, Eleonora L. Swart, et al.. (2009). Noninvasive functional liver blood flow measurement: comparison between bolus dose and steady-state clearance of sorbitol in a small-rodent model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 298(2). G177–G181. 5 indexed citations
4.
Ginneken, Berbke T.J. van, Rita J. G. van den Berg-Emons, Anna E. van der Windt, et al.. (2009). Persistent fatigue in liver transplant recipients: a two‐year follow‐up study. Clinical Transplantation. 24(1). E10–6. 52 indexed citations
5.
Meerten, E. van, Ate van der Gaast, H.W. Tilanus, et al.. (2009). Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: The rotterdam experience. Journal of Surgical Oncology. 100(1). 32–37. 23 indexed citations
6.
Sewgobind, Varsha D. K. D., Luc J. W. van der Laan, Mariska Klepper, et al.. (2008). Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor‐directed responses after transplantation. Clinical Transplantation. 22(5). 579–586. 14 indexed citations
7.
Moreels, Tom G., Evelyn P.M. van Vliet, H.W. Tilanus, et al.. (2007). Down syndrome and esophageal cancer. Diseases of the Esophagus. 20(2). 183–186. 3 indexed citations
8.
Boor, Patrick P.C., Herold J. Metselaar, Shanta Mancham, et al.. (2006). Prednisolone Suppresses the Function and Promotes Apoptosis of Plasmacytoid Dendritic Cells. American Journal of Transplantation. 6(10). 2332–2341. 55 indexed citations
9.
Buise, Marc P., et al.. (2006). Intravenous nitroglycerin does not preserve gastric microcirculation during gastric tube reconstruction: a randomized controlled trial.. Critical Care. 10(5). R131–R131. 21 indexed citations
10.
Cense, Huib A., Casper H.J. van Eijck, & H.W. Tilanus. (2006). New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Practice & Research Clinical Gastroenterology. 20(5). 893–906. 55 indexed citations
11.
Lanschot, J.J.B. van, H.W. Tilanus, & H. Obertop. (2003). Surgical treatment of esophageal cancer - Reply (letter). New England Journal of Medicine. 348(12). 1178–1179. 1 indexed citations
12.
Polée, M., H.W. Tilanus, F. Eskens, et al.. (2003). Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. Annals of Oncology. 14(8). 1253–1257. 14 indexed citations
13.
Hulscher, Jan B.F., Angela G. E. M. de Boer, Johanna W. van Sandick, et al.. (2002). No survival benefit of extended transthoracic resection over limited transhiatal resection for adenocarcinoma of the mid/distal esophagus and gastric cardia: results of a randomized study.. New England Journal of Medicine. 21. 1662–1669. 12 indexed citations
14.
Willems, M., et al.. (2002). Liver transplantation and hepatitis C. Transplant International. 15(2-3). 61–72. 33 indexed citations
15.
Polée, M., Ferry A.L.M. Eskens, M.E.L. van der Burg, et al.. (2002). Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. British Journal of Cancer. 86(5). 669–673. 63 indexed citations
16.
Boogert, Jolanda van den, Richard van Hillegersberg, Hugo J. van Staveren, et al.. (1999). Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus. British Journal of Cancer. 79(5-6). 825–830. 18 indexed citations
17.
Baan, Carla C., Hubert G.M. Niesters, Herold J. Metselaar, et al.. (1998). Increased intragraft IL‐15 mRNA expression after liver transplantation. Clinical Transplantation. 12(3). 212–218. 22 indexed citations
18.
Tilanus, H.W., T.C. Kok, & W M H Eijkenboom. (1993). [Current viewpoints in the treatment of esophageal carcinoma].. PubMed. 137(9). 444–7.
19.
Kok, T.C., Ate van der Gaast, Ted A.W. Splinter, & H.W. Tilanus. (1991). Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. European Journal of Cancer and Clinical Oncology. 27(9). 1112–1114. 1 indexed citations
20.
Lamberts, Steven W. J., et al.. (1988). Successful Treatment with SMS 201-995 of Cushing’s Syndrome Caused by Ectopic Adrenocorticotropin Secretion From a Metastatic Gastrin-Secreting Pancreatic Islet Cell Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 67(5). 1080–1083. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026